Connect with us

The Guardians of Democracy

The Guardians of Democracy

Pfizer Abruptly Kills Research Into Cures For Alzheimer’s and Parkinson’s, Terminates 300 Employees

Corporate Greed

Pfizer Abruptly Kills Research Into Cures For Alzheimer’s and Parkinson’s, Terminates 300 Employees





Pharmaceutical giant Pfizer has abruptly ended research into new neuroscience drugs for Alzheimer’s disease and Parkinson’s disease, resulting in the termination of 300 employees, the company said.

“This was an exercise to reallocate [spending] across our portfolio, to focus on those areas where our pipeline, and our scientific expertise, is strongest,” Pfizer said in a statement this weekend.

Pfizer it will start a venture fund committed to neuroscience and will continue research into neurological drugs for rare diseases.



The Hill notes:

The company said it will continue its support of a late-stage pain treatment drug, tanezumab, and Lyrica, a drug for fibromyalgia.

The company had invested heavily in discovering new drugs for Alzheimer’s and Parkinson’s, but those efforts were costly and didn’t produce results.




Continue Reading
Advertisement
You may also like...
Comments

More in Corporate Greed

To Top